{
  "id": "789a0123-c45d-67e8-f901-234567890def",
  "facility": "Fremont",
  "ppsCode": "RD2024X",
  "targetDose": "10+10+5",
  "doseRangeLow": 22.5,
  "doseRangeHigh": 27.5,
  "turnaround": "Standard",
  "envCondition": "Frozen",
  "materials": [
    {
      "id": "mat-split-001",
      "productName": "Heat-Sensitive Biologic",
      "lotNumber": "BIO2024003",
      "quantity": 250,
      "packaging": "Cryogenic vials in insulated containers",
      "temperatureRequirement": "-80°C storage, -20°C processing"
    }
  ],
  "deaData": null,
  "signature": {
    "data": "iVBORw0KGgoAAAANSUhEUgAAAAMAAAADCAYAAABWKLW/AAAAEklEQVR42mP8/5+BgZEBAzAyMDAAA/8C/P8C1Q0AAAAASUVORK5CYII=",
    "timestamp": "2024-07-31T11:45:22.000Z",
    "signerName": "Dr. Sarah Johnson",
    "signerTitle": "R&D Director",
    "hash": "9f8e7d6c5b4a3928174650928374659283746592837465928374659283746592"
  },
  "status": "signed",
  "createdAt": "2024-07-31T11:20:00.000Z",
  "updatedAt": "2024-07-31T11:45:22.000Z",
  "customerId": "cust-003",
  "specialInstructions": "Split dose irradiation required - 10 kGy + 10 kGy + 5 kGy with 24-hour intervals between doses. Maintain frozen temperature throughout process.",
  "estimatedCompletionDate": "2024-08-07T17:00:00.000Z",
  "priority": "standard",
  "processingNotes": {
    "doseSequence": [
      {
        "sequence": 1,
        "targetDose": 10,
        "toleranceLow": 9.0,
        "toleranceHigh": 11.0,
        "waitPeriod": "24 hours"
      },
      {
        "sequence": 2,
        "targetDose": 10,
        "toleranceLow": 9.0,
        "toleranceHigh": 11.0,
        "waitPeriod": "24 hours"
      },
      {
        "sequence": 3,
        "targetDose": 5,
        "toleranceLow": 4.5,
        "toleranceHigh": 5.5,
        "waitPeriod": null
      }
    ],
    "totalProcessingTime": "72 hours minimum",
    "specialRequirements": [
      "Maintain -20°C throughout irradiation",
      "Monitor dose uniformity after each pass",
      "Document temperature excursions if any"
    ]
  },
  "rndProtocolDetails": {
    "studyId": "RD-2024-BIO-003",
    "principalInvestigator": "Dr. Sarah Johnson",
    "objectiveType": "dose_optimization",
    "expectedOutcome": "Determine minimum effective split dose schedule",
    "dataCollectionPoints": [
      "Post-dose 1: Viability assessment",
      "Post-dose 2: Structural integrity", 
      "Post-dose 3: Final efficacy testing"
    ]
  }
}
